245 related articles for article (PubMed ID: 22294578)
21. Current European regulations for control of adventitious virus safety.
Blümel J
PDA J Pharm Sci Technol; 2011; 65(6):568-79. PubMed ID: 22294579
[TBL] [Abstract][Full Text] [Related]
22. A microarray platform for virus detection and identification.
Munroe D
PDA J Pharm Sci Technol; 2011; 65(6):691. PubMed ID: 22294600
[TBL] [Abstract][Full Text] [Related]
23. Chlorine dioxide remediation of a virus-contaminated manufacturing facility.
Lutgen M
PDA J Pharm Sci Technol; 2011; 65(6):620-4. PubMed ID: 22294587
[TBL] [Abstract][Full Text] [Related]
24. PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.
King K; Wiebe M
PDA J Pharm Sci Technol; 2011; 65(6):693. PubMed ID: 22294602
[TBL] [Abstract][Full Text] [Related]
25. Advanced Techniques for Detection and Identification of Viral Contaminants Using the Ibis PLEX-ID Universal Biosensor.
Sampath R
PDA J Pharm Sci Technol; 2011; 65(6):690. PubMed ID: 22294599
[TBL] [Abstract][Full Text] [Related]
26. Summary of breakout session e.
Brorson K; Lubiniecki A
PDA J Pharm Sci Technol; 2011; 65(6):616-9. PubMed ID: 22294586
[TBL] [Abstract][Full Text] [Related]
27. Summary of Breakout Session B: Regulatory Expectations for CGMP.
Sausville R; Cazeault C
PDA J Pharm Sci Technol; 2011; 65(6):713-4. PubMed ID: 22294605
[TBL] [Abstract][Full Text] [Related]
28. Summary of breakout session f: facility and equipment decontamination strategies.
Norwood LP; Suvarna K
PDA J Pharm Sci Technol; 2011; 65(6):625-6. PubMed ID: 22294588
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a single-platform, rapid, nucleic Acid-based technology for detection of adventitious contaminants of cell culture.
Dehghani H; Lawrence B; Ill RC
PDA J Pharm Sci Technol; 2011; 65(6):675-80. PubMed ID: 22294596
[TBL] [Abstract][Full Text] [Related]
30. Massively parallel sequencing for the detection of adventitious viruses.
Kolman JL
PDA J Pharm Sci Technol; 2011; 65(6):663-7. PubMed ID: 22294594
[TBL] [Abstract][Full Text] [Related]
31. Nanostring's nCounter--A True Digital Target Profiling Technology.
Morrow M; Donaldson J
PDA J Pharm Sci Technol; 2011; 65(6):692. PubMed ID: 22294601
[TBL] [Abstract][Full Text] [Related]
32. Breakout session C summary: current virus detection methods.
Byrnes AP; Willkommen H
PDA J Pharm Sci Technol; 2011; 65(6):660-2. PubMed ID: 22294593
[TBL] [Abstract][Full Text] [Related]
33. Mouse Minute Virus (MMV) Contamination--A Case Study: Detection, Root Cause Determination, and Corrective Actions.
Moody M; Alves W; Varghese J; Khan F
PDA J Pharm Sci Technol; 2011; 65(6):580-8. PubMed ID: 22294580
[TBL] [Abstract][Full Text] [Related]
34. Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq(R) for the Presence of Porcine Circovirus.
Ranucci CS; Tagmyer T; Duncan P
PDA J Pharm Sci Technol; 2011; 65(6):589-98. PubMed ID: 22294581
[TBL] [Abstract][Full Text] [Related]
35. Detection of adventitious viruses from biologicals using a broad-spectrum microbial detection array.
Jaing C; Gardner S; McLoughlin K; Thissen JB; Slezak T
PDA J Pharm Sci Technol; 2011; 65(6):668-74. PubMed ID: 22294595
[TBL] [Abstract][Full Text] [Related]
36. Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.
Ma J; Kreil TR
PDA J Pharm Sci Technol; 2018; 72(5):511-515. PubMed ID: 30030359
[TBL] [Abstract][Full Text] [Related]
37. Detection of Latent Retroviruses in Vaccine-related Cell Substrates: Investigation of RT Activity Produced by Chemical Induction of Vero Cells.
Ma H; Khan AS
PDA J Pharm Sci Technol; 2011; 65(6):685-9. PubMed ID: 22294598
[TBL] [Abstract][Full Text] [Related]
38. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
[TBL] [Abstract][Full Text] [Related]
39. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
[TBL] [Abstract][Full Text] [Related]
40. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
